Bnp Paribas Asset Management Holding S.A. Guardant Health, Inc. Transaction History

Bnp Paribas Asset Management Holding S.A.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$28.82 - $77.35 $235,776 - $632,800	-8,181 Reduced 4.19%	186,860 $7.54 Million
Q1 2022 May 12, 2022	SELL	$48.25 - $100.49 $376,687 - $784,525	-7,807 Reduced 3.85%	195,041 $12.9 Million
Q4 2021 Feb 09, 2022	BUY	$88.71 - $120.43 $511,501 - $694,399	5,766 Added 2.93%	202,848 $20.3 Million
Q3 2021 Nov 08, 2021	BUY	$98.77 - $132.17 $234,381 - $313,639	2,373 Added 1.22%	197,082 $24.6 Million
Q2 2021 Aug 05, 2021	BUY	$109.77 - $165.68 $7.46 Million - $11.3 Million	67,927 Added 53.58%	194,709 $24.2 Million
Q1 2021 May 05, 2021	BUY	$127.04 - $179.1 $16.1 Million - $22.7 Million	126,782 New	126,782 $19.4 Million

323

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.75B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Bnp Paribas Asset Management Holding S.A., based on Form 13F filings with the SEC.

Stay updated on Bnp Paribas Asset Management Holding S.A. with notifications on news.